Synthesis and anti-bacterial activity of barbituric acid derivatives
BLDEAS SSM college of pharmacy and research centre Vijayapura.
Research Article
World Journal of Advanced Research and Reviews, 2024, 21(03), 1863–1870
Publication history:
Received on 08 February 2024; revised on 18 March 2024; accepted on 20 March 2024
Abstract:
When the viable solve the ents businesses launched penicillin, in the establishment of 19th century vented by Alexander Fleming, a major reduction in the number of deaths caused by bacterial infections was confirmed. Optimists have even noticed an end to the period of bacterial diseases. However, to the request, and frequently improper, applications of antibiotics have resulted in the development of drug-the resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), WHO generated a list of priority pathogens to focus the development of new antibacterial drugs against; MRSA ranked as a high priority. Unfortunately, the development of new antibacterial drugs has progressively declined since the 1980s. In my the research work novel derivatives of Barbituric acid obtained from Methyl propyl malonate and Thiourea give 5-methyl-5-propyl-2-sulfanyl Barbituric Acid [ST-I] it was treated with Alkyl Halides gives 5-methyl-5-propyl-2-sulfanyl Barbituric Acid Derivatives which is converted into resultant compound derivatives of (ST-IA to ST-IE). All the compounds synthesized were confirmed by spectral data and evaluated for their methicillin-resistant Staphylococcus aureus (MRSA) activity Vancomycin was used as standard. The compounds DR-IIA and DR-IID have shown good activity and the remaining show poor activity against bacteria.
Keywords:
Barbituric Acid; Alkyl Halides Chloramphenicol; Antibacterial Activity; Vancomycin; Methicillin-Resistant Staphylococcus aureus (MRSA).
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0